Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out fentanyl exposure. For follow-up testing of a presumptive result, Fentanyl and Metabolite, Urine Quantitative (0092570) is preferred.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives in ARUP Standard Transport Tubes. (Min: 1 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles. Samples collected in tubes with additives or preservatives.

Remarks
Stability

Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

Reference Interval

Interpretive Data

Methodology:  Immunoassay

Positive Cutoff: 1 ng/mL

Compliance Category

FDA

Note

If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test code 0092570) will be added to confirm result. Additional charges apply.

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80354 (Reflexed Alt Code: G0480 )

Components

Component Test Code* Component Chart Name LOINC
2012212 Screen, Urine Interpretation 54247-2
2012285 Fentanyl Screen, Urine 11235-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Innovar
  • sublimaze
  • Durogesic
  • Duragesic
  • Fentanyl and Metabolite
  • norfentanyl
  • onsolis
  • Actiq
  • Instanyl
  • Ionsys
  • fentanyl and norfentanyl blood levels
  • Fentore
Fentanyl , Urine Screen with Reflex to Quantitation